During the past decade, The Guenther Dermatology Research Centre conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 23 clinical trials were completed, i.e. on average, 127.8% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 16 clinical trials were completed. i.e. 228.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Guenther Dermatology Research Centre" #1 sponsor was "LEO Pharma" with 6 trials, followed by "Pfizer" with 6 trials sponsored, "Boehringer Ingelheim" with 4 trials sponsored, "Eli Lilly and Company" with 4 trials sponsored and "Innovaderm Research Inc." with 4 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Guenther Dermatology Research Centre" #1 collaborator was "Abbott" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "Innovaderm Research Inc." with 1 trials as a collaborator and "Schering-Plough" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "The Guenther Dermatology Research Centre" are "Psoriasis" (14 trials), "Psoriasis Vulgaris" (5 trials), "Atopic Dermatitis" (3 trials), "Plaque Psoriasis" (3 trials) and "Actinic Keratosis" (2 trials). Many other conditions were trialed in "The Guenther Dermatology Research Centre" in a lesser frequency.

Most popular intervention types in "The Guenther Dermatology Research Centre" are "Drug" (34 trials), "Other" (3 trials), "Device" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Apremilast" (2 trials), "CP-690,550" (2 trials), "Guselkumab" (2 trials) and "Mirikizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "The Guenther Dermatology Research Centre" are 36 trials for "All" genders.

Currently, there are NaN active trials in "The Guenther Dermatology Research Centre". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in The Guenther Dermatology Research Centre, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in The Guenther Dermatology Research Centre, 2 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".